RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @jcobaya69: Importante reducir hipoglucemias para prevenir complicaciones Cardiovasculares. https://t.co/Do5N6XAEQx
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @jcobaya69: Importante reducir hipoglucemias para prevenir complicaciones Cardiovasculares. https://t.co/Do5N6XAEQx
RT @jcobaya69: Importante reducir hipoglucemias para prevenir complicaciones Cardiovasculares. https://t.co/Do5N6XAEQx
Importante reducir hipoglucemias para prevenir complicaciones Cardiovasculares.
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
RT @Dr_Manito: Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascula…
Estudio DEVOTE 14 (Heart failure with insulin degludec versus glargine U100 in type 2 diabetes at high risk of cardiovascular disease) confirma que las hipoglucemias aumentan el riesgo de hospitalización por insuficiencia cardiaca. Aviso para el uso de Su
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
DEVOTE 14 Degludec vs Glargina 100 #insuficienciacardiaca https://t.co/KaAZiNb4LU https://t.co/ZdCGAF1QhO
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
RT @mendez_bailon: Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high r…
Interesting article "Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14" (via #pubmedontap) @SEDiabetes @redGDPS @Diabetes_SEMI #SEMItuit https://t.co/oZeuQRsfy